Shorter Treatment for Nonsevere Pediatric Tuberculosis: A Single-center Case Series in a Low-burden Country

[1] Turkova A., Wills G.H., Wobudeya E., Chabala C., Palmer M., Kinikar A., Et al., Shorter treatment for nonsevere tuberculosis in African and Indian children, N Engl J Med, 386, pp. 911-922, (2022)

[2] Nahid P., Dorman S.E., Alipanah N., Barry P.M., Brozek J.L., Cattamanchi A., Et al., Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis, Clin Infect Dis, 63, pp. e147-e195, (2016)

[3] WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents, (2022)

[4] Graham S.M., Ahmed T., Amanullah F., Browning R., Cardenas V., Casenghi M., Et al., Evaluation of tuberculosis diagnostics in children. 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis. Consensus from an expert disease panel, J Infect Dis, 205, pp. S199-S208, (2012)

[5] Wiseman C.A., Gie R.P., Starke J.R., Schaaf H.S., Donald P.R., Cotton M.F., Et al., A proposed comprehensive classification of tuberculosis disease severity in children, Pediatr Infect Dis J, 31, pp. 347-352, (2012)

[6] Baquero-Artigao F., del Rosal T., Falcon-Neyra L., Ferreras-Antolin L., Gomez-Pastrana D., Hernanz-Lobo A., Et al., Update on the diagnosis and treatment of tuberculosis, An Pediatr (Engl Ed), 98, pp. 460-469, (2023)

[7] Guix-Comellas E.M., Rozas-Quesada L., Velasco-Arnaiz E., Ferres-Canals A., Estrada-Masllorens J.M., Force-Sanmartin E., Et al., Impact of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: a nonrandomized controlled trial, J Adv Nurs, 74, pp. 1819-1830, (2018)

[8] Noguera-Julian A., Buonsenso D., McKenna L., Seddon J.A., Ritz N., Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe, Eur Respir J, 58, (2021)

[9] Noguera-Julian A., Latre C., Flores A., Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain, Eur Respir J, 63, (2024)

[10] Kumar K., Mathew J.L., World Health Organization Guideline on the management of tuberculosis in children: critical appraisal, concerns, and caution, Indian J Pediatr, 90, pp. 811-816, (2023)

[1] Turkova A., Wills G.H., Wobudeya E., Chabala C., Palmer M., Kinikar A., Et al., Shorter treatment for nonsevere tuberculosis in African and Indian children, N Engl J Med, 386, pp. 911-922, (2022)

[2] Nahid P., Dorman S.E., Alipanah N., Barry P.M., Brozek J.L., Cattamanchi A., Et al., Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis, Clin Infect Dis, 63, pp. e147-e195, (2016)

[3] WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents, (2022)

[4] Graham S.M., Ahmed T., Amanullah F., Browning R., Cardenas V., Casenghi M., Et al., Evaluation of tuberculosis diagnostics in children. 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis. Consensus from an expert disease panel, J Infect Dis, 205, pp. S199-S208, (2012)

[5] Wiseman C.A., Gie R.P., Starke J.R., Schaaf H.S., Donald P.R., Cotton M.F., Et al., A proposed comprehensive classification of tuberculosis disease severity in children, Pediatr Infect Dis J, 31, pp. 347-352, (2012)

[6] Baquero-Artigao F., del Rosal T., Falcon-Neyra L., Ferreras-Antolin L., Gomez-Pastrana D., Hernanz-Lobo A., Et al., Update on the diagnosis and treatment of tuberculosis, An Pediatr (Engl Ed), 98, pp. 460-469, (2023)

[7] Guix-Comellas E.M., Rozas-Quesada L., Velasco-Arnaiz E., Ferres-Canals A., Estrada-Masllorens J.M., Force-Sanmartin E., Et al., Impact of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: a nonrandomized controlled trial, J Adv Nurs, 74, pp. 1819-1830, (2018)

[8] Noguera-Julian A., Buonsenso D., McKenna L., Seddon J.A., Ritz N., Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe, Eur Respir J, 58, (2021)

[9] Noguera-Julian A., Latre C., Flores A., Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain, Eur Respir J, 63, (2024)

[10] Kumar K., Mathew J.L., World Health Organization Guideline on the management of tuberculosis in children: critical appraisal, concerns, and caution, Indian J Pediatr, 90, pp. 811-816, (2023)